ChatDual™ helps life-sciences brands understand, influence, and measure how clinicians engage in the emerging AI-driven clinical ecosystem.

Clinicians increasingly turn to AI tools to explore disease questions, compare therapies, and clarify evidence.

This moment — where clinical curiosity meets AI — has become a defining touchpoint in today’s treatment decisions.

ChatDual™ helps brands navigate this shift responsibly, intelligently, and measurably.

We help identify the clinicians most likely to shape early adoption and digital exploration in your therapeutic area.

We strengthen the clarity and discoverability of your science in places where clinicians increasingly look for answers.

We provide visibility into how these digital exploration behaviors relate to clinical decision-making over time.